FI953747A - Steroideja vaihdevuosivaivojen hoitoon - Google Patents

Steroideja vaihdevuosivaivojen hoitoon Download PDF

Info

Publication number
FI953747A
FI953747A FI953747A FI953747A FI953747A FI 953747 A FI953747 A FI 953747A FI 953747 A FI953747 A FI 953747A FI 953747 A FI953747 A FI 953747A FI 953747 A FI953747 A FI 953747A
Authority
FI
Finland
Prior art keywords
steroids
treatment
menopause disorders
menopause
disorders
Prior art date
Application number
FI953747A
Other languages
English (en)
Swedish (sv)
Other versions
FI953747A0 (fi
FI114101B (fi
Inventor
Hubert Jan Jozef Loozen
Lodewijk Pieter Cornelis Schot
Der Werf-Pieters Jane Marg Van
Original Assignee
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv
Publication of FI953747A0 publication Critical patent/FI953747A0/fi
Publication of FI953747A publication Critical patent/FI953747A/fi
Application granted granted Critical
Publication of FI114101B publication Critical patent/FI114101B/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051—Estrane derivatives
    • C07J1/0081—Substituted in position 17 alfa and 17 beta
    • C07J1/0088—Substituted in position 17 alfa and 17 beta the substituent in position 17 alfa being an unsaturated hydrocarbon group
    • C07J1/0096—Alkynyl derivatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J11/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J21/005—Ketals
    • C07J21/008—Ketals at position 17
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J33/00—Normal steroids having a sulfur-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J33/005—Normal steroids having a sulfur-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton spiro-condensed
    • C07J33/007—Cyclic thioketals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0044—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 with an estrane or gonane skeleton, including 18-substituted derivatives and derivatives where position 17-beta is substituted by a carbon atom not directly bonded to another carbon atom and not being part of an amide group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0094—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 containing nitrile radicals, including thiocyanide radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J51/00—Normal steroids with unmodified cyclopenta(a)hydrophenanthrene skeleton not provided for in groups C07J1/00 - C07J43/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Rheumatology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Reproductive Health (AREA)
  • Epidemiology (AREA)
  • Toxicology (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FI953747A 1993-02-08 1995-08-07 Menetelmä vaihdevuosivaivojen hoitoon käyttökelpoisten steroidien valmistamiseksi FI114101B (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP93200332 1993-02-08
EP93200332 1993-02-08
EP9400348 1994-02-04
PCT/EP1994/000348 WO1994018224A1 (en) 1993-02-08 1994-02-04 Steroids for treating menopausal complaints

Publications (3)

Publication Number Publication Date
FI953747A0 FI953747A0 (fi) 1995-08-07
FI953747A true FI953747A (fi) 1995-09-12
FI114101B FI114101B (fi) 2004-08-13

Family

ID=8213615

Family Applications (1)

Application Number Title Priority Date Filing Date
FI953747A FI114101B (fi) 1993-02-08 1995-08-07 Menetelmä vaihdevuosivaivojen hoitoon käyttökelpoisten steroidien valmistamiseksi

Country Status (15)

Country Link
EP (1) EP0682672A1 (fi)
JP (1) JPH08506116A (fi)
KR (1) KR100364113B1 (fi)
CN (1) CN1046735C (fi)
AU (1) AU4675897A (fi)
BR (1) BR9405825A (fi)
CA (1) CA2155532A1 (fi)
FI (1) FI114101B (fi)
HU (2) HU220615B1 (fi)
NO (1) NO308583B1 (fi)
NZ (1) NZ261581A (fi)
PL (1) PL182901B1 (fi)
RU (1) RU2172740C2 (fi)
WO (1) WO1994018224A1 (fi)
ZA (1) ZA94715B (fi)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW403736B (en) * 1997-02-21 2000-09-01 Akzo Nobel Nv Steroid compounds having contraceptive and anti-osteoporosis activity
IL137541A0 (en) * 1998-03-09 2001-07-24 Akzo Nobel Nv New contraceptive kit
US6677329B1 (en) * 1999-09-06 2004-01-13 Akzo Nobel N V. Non-aromatic estrogenic steroids with a hydrocarbon substituent in position 11
BR0112791A (pt) 2000-07-28 2003-06-24 Akzo Nobel Nv Composto esteroidal 16alfa-substituido, uso do mesmo, métodos de tratamento para ativação seletiva de receptores de estrogênio do subtipo alfa, e para terapia de reposição hormonal ou contracepção, e, composição farmacêutica
UA89964C2 (ru) 2004-09-08 2010-03-25 Н.В. Органон 15β-ЗАМЕЩЕННЫЕ СТЕРОИДЫ, КОТОРЫЕ ИМЕЮТ СЕЛЕКТИВНУЮ ЭСТРОГЕННУЮ АКТИВНОСТЬ
HUE055367T2 (hu) * 2016-03-03 2021-11-29 Crystal Pharma Sau Eljárás új intermedierek 11-metilén-szteroidok elõállítására

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3325520A (en) * 1965-12-08 1967-06-13 Searle & Co (optionally 17-hydrocarbon-substituted) 11, 13beta-dialkylgon-4-en-3-ones and esters corresponding
US3465010A (en) * 1966-11-22 1969-09-02 Searle & Co 17 - (unsaturated hydrocarbon - substituted) 11,13beta - dialkylgon -4 - ene - 3,17beta-diols and esters thereof
NL175063C (nl) * 1972-12-09 1984-09-17 Akzo Nv Werkwijze ter bereiding van 11,11-alkylideensteroiden, werkwijze ter bereiding van farmaceutische preparaten en gevormde farmaceutische preparaten.
US3927046A (en) * 1972-12-09 1975-12-16 Akzona Inc Novel 11,11-alkylidene steroids
NL7317358A (nl) * 1973-12-19 1975-06-23 Akzo Nv Nieuwe 11(beta)-alkylsteroiden van de oestraanreeks.
NL7701384A (nl) * 1977-02-10 1978-08-14 Akzo Nv Werkwijze voor het bereiden van nieuwe steroiden van de oestraanreeks.
AU532512B2 (en) * 1979-09-07 1983-10-06 Upjohn and Horton Anti-allergenic compounds for bone mineral resorption
US4826831A (en) * 1983-08-05 1989-05-02 Pre Jay Holdings Limited Method of hormonal treatment for menopausal or post-menopausal disorders involving continuous administration of progestogens and estrogens
AU572589B2 (en) * 1983-12-14 1988-05-12 Upjohn Company, The 11(alpha)-difluoromethyl and (e)-and (z)-11-fluoromethylene steroids
NL8502571A (nl) * 1985-09-20 1987-04-16 Akzo Nv Steroiden met immunomodulerende eigenschappen.
DE3702383A1 (de) * 1987-01-23 1988-08-04 Schering Ag 11ss-alkinylestrene und -estradiene, deren herstellung und diese enthaltende pharmazeutische praeparate
HUT52382A (en) * 1988-03-14 1990-07-28 Sandoz Ag Process for producing pharmaceutical compositions comprising as active ingredient unsubstituted progestin in 19-position and estrogen in the given case
DE59004243D1 (de) * 1990-06-14 1994-02-24 Henning Berlin Gmbh Flüssig befüllte Steckkapselpräparate.
AU8166191A (en) * 1990-08-10 1992-02-13 Ortho Pharmaceutical Corporation Method for treatment of bone wasting diseases

Also Published As

Publication number Publication date
KR100364113B1 (ko) 2003-04-08
EP0682672A1 (en) 1995-11-22
CA2155532A1 (en) 1994-08-18
NO953089D0 (no) 1995-08-07
FI953747A0 (fi) 1995-08-07
HUT72971A (en) 1996-06-28
HU0102320D0 (en) 2001-08-28
CN1046735C (zh) 1999-11-24
AU682170B2 (en) 1997-09-25
FI114101B (fi) 2004-08-13
ZA94715B (en) 1994-10-24
RU2172740C2 (ru) 2001-08-27
NO953089L (no) 1995-10-06
NO308583B1 (no) 2000-10-02
PL182901B1 (pl) 2002-03-29
BR9405825A (pt) 1995-12-05
WO1994018224A1 (en) 1994-08-18
NZ261581A (en) 1997-06-24
AU4675897A (en) 1998-02-19
HU220615B1 (hu) 2002-03-28
CN1117735A (zh) 1996-02-28
PL310125A1 (en) 1995-11-27
AU6039494A (en) 1994-08-29
HU9501940D0 (en) 1995-09-28
JPH08506116A (ja) 1996-07-02

Similar Documents

Publication Publication Date Title
DE122009000012I1 (de) Substituierte pyrazolyl-benzolsulfonamide zur behandlung von entzundungen.
NO934304L (no) Fremgangsmaate for behandling av fluoralumosilikatglass
HK1042475A1 (zh) 用於治療炎癥的取代噻唑
FI931657A0 (fi) Menetelmä endo-osteaalisten materiaalien käsittelemiseksi
ZA961150B (en) Substituted isoxazoles for the treatment of inflammation.
DE69315257T2 (de) Simethicon enthaltende Arzneimittel zur Behandlung gastrointestinaler Störungen
FI954119A (fi) Menetelmä kiinteän jätteen käsittelemiseksi
FI962370A0 (fi) Laite tissuen valmistamiseksi
NO953254D0 (no) Substituerte azolonderivater for behandling av sykdommer forårsaket av helikobakter
FI953747A (fi) Steroideja vaihdevuosivaivojen hoitoon
NO991734D0 (no) Pyrazolinoner for behandling av potensforstyrrelser
NO974569L (no) Benzamider for behandling av neurodegenerative forstyrrelser
NO913117L (no) Fremgangsmaate for behandling av benoedeleggende sykdommer.
FI942394A0 (fi) Menetelmä steroidiperasyyliglykosidien valmistamiseksi
NO973366D0 (no) Fremgangsmåte for behandling av multippel sklerose
FI980091A0 (fi) Menetelmä ylijäämäaktiivilietteen käsittelemiseksi
NO920983L (no) Fremgangsmaate for behandling av nevrodegenerative tilstander
NO952411D0 (no) Midler for behandling av metaboliske bensykdommer
FI102841B1 (fi) Menetelmä mannitolin valmistamiseksi
ZA944671B (en) Medicaments for the treatment of inflammatory diseases
NO962812D0 (no) Fremgangsmåte for behandling av nervebetennelse
FI951441A (fi) Menetelmä 5-formyyliamino-pyrimidiinien valmistamiseksi
FI931228A (fi) Foerfarande foer framstaellning av karboxylsyraklorider av aromatiska kvaeve-heterocykliska foereningar
NO964631L (no) FremgangsmÕte for fremstilling av vesentlig bakteriefritt kolostrum
NO945001D0 (no) Steroide glykosider for behandling av hyperkolestrolemi

Legal Events

Date Code Title Description
MA Patent expired